Evidence map›Paper›PMID 40621512›Full record

ArticlePakistan journal of medical sciences2025

Efficacy of donepezil combined with rehabilitation training in the treatment of Alzheimer's disease.

Yi Yi, Xiaoyan Deng

Abstract read
In one paragraph

Article in Pakistan journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yi YiYi Yi, Department of Neurology, The First Affiliated Hospital of Chongqing Medical and Pharmaceutical College, Chongqing, 400060, P.R. China.
Xiaoyan DengXiaoyan Deng, Department of Neurology, The First Affiliated Hospital of Chongqing Medical and Pharmaceutical College, Chongqing, 400060, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To examine the efficacy of donepezil combined with rehabilitation training for treating Alzheimer's disease (AD) and its impact on nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF). Methods: This single center retrospective analysis was conducted at the First Affiliated Hospital of Chongqing Medical and Pharmaceutical College and included 184 patients with AD treated between January 2022 to May 2024. Of them, 92 patients who received donepezil combined with rehabilitation training (combined group) were matched in a 1:1 ratio with a cohort that received donepezil alone (donepezil group). The treatment efficacy, cognitive function, ability to engage in daily living activity before and after the treatment, serum NGF and BDNF levels, and incidence of adverse reactions were compared between the two groups. Results: The total efficacy of patients in the combined group was higher than that of the donepezil group ( Conclusions: Compared with donepezil alone, the combination of donepezil and rehabilitation training is associated with significantly improved therapeutic effects and better serum NGF and BDNF levels.

Indexed as

Alzheimer’s diseaseBrain-derived neurotrophic factorDonepezilNerve growth factorRehabilitation training

Identifiers

PMID40621512
PMCPMC12223732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.